Mutual Fund AMCs: AUM Growth vs Shareholder Value
Indian mutual fund AMCs are caught in a paradox - record AUM growth isn't translating to shareholder returns. Discover why bigger isn't always better in the ₹50 lakh crore industry.
Category : Search result: pharma industry regulations
SEBI Shakes Up Mutual Fund Fee Structure
India's mutual fund industry faces major disruption as SEBI proposes sweeping changes to fee structures, potentially reducing AMC profits while increasing distributor commissions. Learn how this could impact your SIP investments.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
Mumbai Studio Safety Crisis: AICWA Demands Action
Following the shocking Powai hostage incident, the All India Cine Workers Association demands urgent safety audits and stricter regulations for film studios across Maharashtra to prevent future tragedies.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
US Push for Affordable Biotech Drugs: India's Opportunity
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Hiten Tejwani: 22-hour work days, dozed off driving
Popular TV actor Hiten Tejwani reveals extreme work conditions in Indian television industry - 22-hour shifts for a month, earning just ₹1 lakh, and dangerous exhaustion that led to falling asleep at wheel.
Mukul Agrawal's ₹200 Cr Pharma Stock Bet Revealed
Discover why prominent investor Mukul Agrawal is betting big on a small-cap pharma company with massive growth potential. Get exclusive insights into his latest portfolio move and what it means for retail investors.
Govt to hike print ad rates by 26% in media reforms
Major media reforms underway as Indian government prepares significant rate revisions for print, radio, TV, and DTH sectors to support industry growth.
Dr. Reddy's Legacy: Transforming Indian Pharma
Discover how Dr. Anji Reddy's visionary journey from generics to innovative drug research positioned India as a global pharmaceutical powerhouse and continues to inspire future generations.
Bangladeshi generic drug slashes rare disease treatment cost by 96%
In a revolutionary healthcare development, Bangladesh's Beximco Pharma launches affordable generic version of lifesaving rare disease drug, dramatically reducing treatment costs from crores to lakhs for patients across South Asia.
Sigachi Q2: Profit Halves, Revenue Down 19%
Sigachi Industries faces turbulent quarter with net profit crashing to ₹10.5 crore amid significant revenue decline. What's behind the pharmaceutical giant's disappointing performance?
Cipla Shares Fall 3% Despite Eli Lilly Weight Loss Drug Deal
Cipla's stock faces unexpected pressure despite securing rights to manufacture and distribute Eli Lilly's revolutionary weight loss drug Mounjaro in India. Discover why investors remain cautious.
Cipla-Eli Lilly deal brings weight loss drugs to India
Indian pharmaceutical giant Cipla announces landmark deal with Eli Lilly to manufacture and distribute popular weight loss medications Mounjaro and Zepbound in India under different brand names.
Aurobindo Pharma Expands to Chile with New Subsidiary
Indian pharma giant Aurobindo Pharma establishes new subsidiary in Chile, marking strategic expansion across South American markets with focus on branded prescriptions and over-the-counter medicines.
Chandigarh Pharma Quality Summit Sets New Standards
Leading pharmaceutical experts gathered in Chandigarh for a crucial conference on drug quality and regulatory compliance, focusing on improving manufacturing practices and patient safety across India.
Torrent Pharma gets CCI nod for JB Chemicals stake
In a major pharmaceutical industry move, Torrent Pharmaceuticals receives Competition Commission of India approval to acquire controlling stake in JB Chemicals & Pharmaceuticals, marking significant consolidation in Indian pharma sector.
Indian Pharma Wins Crucial Legal Battle for Generic Drugs
A significant legal triumph for India's pharmaceutical sector strengthens the position of generic drug makers against patent challenges. Explore how this ruling impacts affordable medicine production and India's role as the 'Pharmacy of the World'.
Novo Nordisk Board Reshuffle: New Faces at the Helm
Danish pharma giant Novo Nordisk, the company behind diabetes & weight-loss blockbusters Ozempic and Wegovy, announces a major boardroom reshuffle. Get the inside scoop on the new faces and strategic direction.
Top 10 Self-Made Women Billionaires in Healthcare
Meet the trailblazing female entrepreneurs who built healthcare empires from scratch and are reshaping medical innovation worldwide. Discover their inspiring journeys to billions.
Nigerian Drug Cartels Recruit Indian Pharma Students: Delhi Police
Delhi Police uncovers how Nigerian drug cartels are recruiting Indian students from pharma colleges, providing specialized training, and creating sophisticated dispatch systems to smuggle narcotics globally.
Zydus vs Rubicon: Pharma Stock Analysis
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
Indian Pharma Q2 Preview: Steady Growth Amid Challenges
India's pharmaceutical sector gears up for Q2 FY25 with projected 5-7% revenue growth, navigating US pricing pressures and domestic GST reductions while maintaining stable profitability.
NCB busts high-tech drug lab in Ratlam, arrests pharma grads
In a major breakthrough, Narcotics Control Bureau uncovers sophisticated drug manufacturing unit in Madhya Pradesh's Ratlam district. Highly educated pharma graduates among those arrested in interstate narcotics operation.
India Mandates QR Codes on All Essential Medicines
India mandates safety QR codes on all essential medicines in public healthcare, transforming drug safety and combating counterfeit drugs with digital innovation.
India's New Prescription for Children's Cough Syrups
Discover how India is transforming its approach to pediatric cough syrups with new regulations, bitter-tasting alternatives, and enhanced safety measures following global health concerns.
MP SIT to Make More Arrests in Pharma Tragedy
Madhya Pradesh's Special Investigation Team gears up for significant arrests in the Sresan Pharma cough syrup case that claimed young lives. Exclusive details on the expanding investigation.
Supreme Court allows generic SMA drug in blow to Roche
In a landmark judgment, India's Supreme Court allows Natco Pharma to produce affordable generic version of Roche's expensive spinal muscular atrophy treatment, making life-saving therapy accessible to thousands.
Page 4 of 4